UBS Group’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-99,358
| Closed | -$633K | – | 8935 |
|
|
2023
Q4 | $633K | Buy |
99,358
+65,154
| +190% | +$415K | ﹤0.01% | 3794 |
|
|
2023
Q3 | $147K | Buy |
34,204
+871
| +3% | +$3.75K | ﹤0.01% | 4478 |
|
|
2023
Q2 | $86K | Hold |
33,333
| – | – | ﹤0.01% | 5081 |
|
|
2023
Q1 | $228K | Sell |
33,333
-1,129
| -3% | -$7.71K | ﹤0.01% | 4255 |
|
|
2022
Q4 | $248K | Buy |
34,462
+49
| +0.1% | +$353 | ﹤0.01% | 4219 |
|
|
2022
Q3 | $361K | Buy |
34,413
+777
| +2% | +$8.15K | ﹤0.01% | 3635 |
|
|
2022
Q2 | $439K | Sell |
33,636
-12
| -0% | -$157 | ﹤0.01% | 3429 |
|
|
2022
Q1 | $565K | Buy |
+33,648
| New | +$565K | ﹤0.01% | 3675 |
|
|
2021
Q4 | – | Sell |
-33
| Closed | -$2K | – | 9576 |
|
|
2021
Q3 | $2K | Buy |
+33
| New | +$2K | ﹤0.01% | 7869 |
|